XML 104 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Revenue:     $ 50,000
Costs and expenses:        
Selling, general and administrative (including stock-based compensation) $ 148,000 $ 40,000 315,000 325,000
Sales and marketing 8,000 17,000    
Professional Services 278,000 280,000 1,262,000 722,000
Research & Development 50,000 179,000 1,147,000 1,226,000
Amortization 280,000 280,000 1,120,000 1,113,000
Other General Expenses     184,000 68,000
Other operating expenses 7,000 7,000    
Total costs and expenses 771,000 803,000 4,028,000 3,454,000
Operating loss (771,000) (803,000) (4,028,000) (3,404,000)
Other income (expense):        
Interest income 3,000 3,000 13,000 24,000
Other income 52,000 52,000 66,000
Interest expense (230,000) (101,000) (444,000) (462,000)
Impairment of investment     (4,100,000)
Loss from operations before income taxes (998,000) (849,000) (4,407,000) (7,876,000)
Income tax benefit 621,000
Net loss (998,000) (849,000) (4,407,000) (7,255,000)
Loss from operations attributed to noncontrolling interest 36,000 192,000 71,000 204,000
Net loss attributable to common stockholders $ (962,000) $ (657,000) $ (4,336,000) $ (7,051,000)
Loss per common share:        
Basic $ (0.10) $ (0.01) $ (0.07) $ (0.10)
Diluted $ (0.10) $ (0.01) $ (0.07) $ (0.10)
Shares used in computing loss per common share:        
Basic 10,000,000 70,496,041 60,248,078 70,496,041
Diluted 10,000,000 70,496,041 60,248,078 70,496,041